Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug Conjugate(ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • Medicilon Inhalation Formulation R&D Platform
      • Preclinical Ophthalmic Research Platform
      • mRNA Vaccine Bioanalysis Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • Medicilon Inhalation Formulation R&D Platform
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
      • Medicilon Metabolite Identification (MetlD) Service Platform
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Generics Consistency Evaluation

Home Service Generics Consistency Evaluation

Generic Medicine Evaluation of Consistency Quality Services

  • Quality Comparison of the Preparations and Generic Drugs
  • Prescription Technology Redevelopment Services
  • Animal BE Service

Medicilon Provide Generic Drug Quality Consistency Workflow

  • Determine the Reference Formulation
  • Method of Determining Key Indicators
  • Comprehensive Comparison between Reference and Generic Drugs
  • Re-development of Prescription and Manufacture Process
  • Pilot Production Scale Up, Production Technology Transfer
  • Animal BE Services (Optional)
  • Data Collation
Contact Us

Share

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

  • Medicilon's Formulation
  • Medicilon Formulation
  • Medicilon Formulation Lab
  • Medicilon Formulation Equipment
  • Medicilon Drug Formulation
  • Formulation
  • Formulation Medicilon

You May Also Like

  • Integrated Projects

    Integrated Projects

    Integrated Projects

  • Drug Safety Evaluation

    Drug Safety Evaluation

    Drug Safety Evaluation

  • Bioanalytical Services

    Bioanalytical Services

    Bioanalytical Services

  • Pharmacokinetic Services

    Pharmacokinetic Services

    Pharmacokinetic Services

  • Pharmacology Services

    Pharmacology Services

    Pharmacology Services

  • Biology Services

    Biology Services

    Biology Services

  • Drug Formulation

    Drug Formulation

    Drug Formulation

  • Chemistry Services

    Chemistry Services

    chemistry

    Chemistry Services

    chemistry

Recent News

  • The 19th Annual San Diego BioPharma Conference

    Agenda 9:00 am Welcome and Opening Remarks Tao Wu, PhD, President, SABPA Yi Liu, PhD, Chair,

    Read More
  • Medicilon won the "Science and Technology Innovation Service Demonstration Case" Award

    Medicilon won the “Science and Technology Innovation Service Demonstration Case” Award

    During September 2 to 7, the 2021 China International Fair for Trade in Services (CIFTIS) co-sponsored

    Read More
  • Dr. Hong Wan as Vice President of Pharmacokinetics and Bioanalysis Department

    Medicilon appoints Dr. Hong Wan as Vice President of DMPK and Bioanalysis Department

    Recently, Shanghai Medicilon Inc. (stock code: 688202.SH) (Medicilon) announced the appointment of Dr. Hong Wan as

    Read More
  • Kumquat Biosciences and Eli Lilly have reached a partnership to jointly develop tumor immune small molecule drugs

    Kumquat Biosciences and Eli Lilly have reached a partnership to jointly develop tumor immune small molecule drugs

    Recently, Loxo Oncology, a research and development group of Eli Lilly, and Kumquat Biosciences (Kumquat) announced

    Read More
  • Qing Ruan examined Medicilon

    Qing Ruan, Deputy Director of Shanghai Municipal Development and Reform Commission, and his team examined Medicilon

    On August 4, 2021, Mr. Qing Ruan, Deputy Director of Shanghai Municipal Development and Reform Commission,

    Read More
  • RG001

    Medicilon assists Ringene Biopharma ‘s SHP2 allosteric inhibitor RG001 tablet to be approved for clinical use

    Recently, Shanghai Ringene Biopharma (Ringene) announced that the company’s self-developed anti-tumor class I new drug SHP2

    Read More
  • Leado Pharma

    Medicilon assists Leado Pharma to obtain clinical approval for small molecule inhibitor LDS tablets targeting transient receptor potential channels

    On July 28, 2021, the Class 1 innovative drug LDS tablets developed by Shanghai Leado Pharma

    Read More
  • new drugs ai innov forum

    Medicilon’s “New Drugs + AI Innov Forum” was successful held

    When AI accurately predicts the “difficult” protein 3D structure; When AI completes the new drug design

    Read More

Interested in our expertise?

Let's Start the Conversation

Contact Us

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug Conjugate(ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • Medicilon Inhalation Formulation R&D Platform
      • Preclinical Ophthalmic Research Platform
      • mRNA Vaccine Bioanalysis Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • Medicilon Inhalation Formulation R&D Platform
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
      • Medicilon Metabolite Identification (MetlD) Service Platform
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc